SARS-CoV / SARS-CoV-2 Nucleocapsid 兔多抗

1, Xiao F, et al. Evidence for gastrointestinal infection of SARS-CoV-2.Gastroenterology, PubMed ID: 32142773
2, Su H, et al. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China.Kidney international, PubMed ID: 32327202
3, Rockx B, et al. Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model.Science (New York, N.Y.), PubMed ID: 32303590
4, Matschke J, et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series.The Lancet. Neurology, PubMed ID: 33031735
5, Youk J, et al. Three-Dimensional Human Alveolar Stem Cell Culture Models Reveal Infection Response to SARS-CoV-2.Cell stem cell, PubMed ID: 33142113
6, Lean FZX, et al. Development of immunohistochemistry and in situ hybridisation for the detection of SARS-CoV and SARS-CoV-2 in formalin-fixed paraffin-embedded specimens.Scientific reports, PubMed ID: 33318594
7, van Kampen JJA, et al. Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19).Nature communications, PubMed ID: 33431879
8, Mykytyn AZ, et al. SARS-CoV-2 entry into human airway organoids is serine protease-mediated and facilitated by the multibasic cleavage site.eLife, PubMed ID: 33393462
9, Zhuang Z, et al. Mapping and role of T cell response in SARS-CoV-2-infected mice.The Journal of experimental medicine, PubMed ID: 33464307
10, Li Y, et al. Remdesivir Metabolite GS-441524 Effectively Inhibits SARS-CoV-2 Infection in Mouse Models.Journal of medicinal chemistry, PubMed ID: 33523654
11, Wang Y, et al. Development of a Broadly Applicable Cas12a-Linked Beam Unlocking Reaction for Sensitive and Specific Detection of Respiratory Pathogens Including SARS-CoV-2.ACS chemical biology, PubMed ID: 33586431
12, Ahn JH, et al. Nasal ciliated cells are primary targets for SARS-CoV-2 replication in the early stage of COVID-19.The Journal of clinical investigation, PubMed ID: 34003804
13, Yuan Y, et al. A bivalent nanoparticle vaccine exhibits potent cross-protection against the variants of SARS-CoV-2.Cell reports, PubMed ID: 34990583
14, Rakislova N, et al. Minimally Invasive Tissue Sampling Findings in 12 Patients With Coronavirus Disease 2019.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, PubMed ID: 34910166
15, Hong X, et al. Evidence of SARS-CoV-2 infection in gallbladder and aggravating cholecystitis to septic shock: a case report.Annals of translational medicine, PubMed ID: 34926675
16, Kang YF, et al. Quadrivalent mosaic HexaPro-bearing nanoparticle vaccine protects against infection of SARS-CoV-2 variants.Nature communications, PubMed ID: 35562337
17, Cheng CC, et al. Improved SARS-CoV-2 Neutralization of Delta and Omicron BA.1 Variants of Concern after Fourth Vaccination in Hemodialysis Patients.Vaccines, PubMed ID: 36016216
18, Bauer L, et al. In vitro and in vivo differences in neurovirulence between D614G, Delta And Omicron BA.1 SARS-CoV-2 variants.Acta neuropathologica communications, PubMed ID: 36058935
19, Svilenov HL, et al. Multimeric ACE2-IgM fusions as broadly active antivirals that potently neutralize SARS-CoV-2 variants.Communications biology, PubMed ID: 36371561
20, Chen X, et al. Investigating Derivatives of Tanshinone IIA Sulfonate Sodium and Chloroxine for Their Inhibition Activities against the SARS-CoV-2 Papain-like Protease.ACS omega, PubMed ID: 36591160
21, Körber N, et al. Comparable cellular and humoral immunity upon homologous and heterologous COVID-19 vaccination regimens in kidney transplant recipients.Frontiers in immunology, PubMed ID: 37063863
22, Ge Q, et al. SARS-CoV-2 neurotropism-induced anxiety and depression-like behaviors require Microglia activation.bioRxiv : the preprint server for biology, PubMed ID: 37873397
23, Cui T, et al. Dynamic immune landscape in vaccinated-BA.5-XBB.1.9.1 reinfections revealed a 5-month protection-duration against XBB infection and a shift in immune imprinting.EBioMedicine, PubMed ID: 38064992
24, Wang F, et al. Discovery of natural catechol derivatives as covalent SARS-CoV-2 3CLpro inhibitors.International journal of biological macromolecules, PubMed ID: 38395279
25, Zhou J, et al. TRIM6 facilitates SARS-CoV-2 proliferation by catalyzing the K29-typed ubiquitination of NP to enhance the ability to bind viral genomes.Journal of medical virology, PubMed ID: 38515377
26, Liao BH, et al. SARS-CoV-2 Neutralization Capacity in Hemodialysis Patients with and without a Fifth Vaccination with the Updated Comirnaty Original/Omicron BA.4-5 Vaccine.Vaccines, PubMed ID: 38543942
27, Granholm AE, et al. Neuropathological findings in Down syndrome, Alzheimer's disease and control patients with and without SARS-COV-2: preliminary findings.Acta neuropathologica, PubMed ID: 38801558
28, Esih H, et al. Mucoadhesive film for oral delivery of vaccines for protection of the respiratory tract.Journal of controlled release : official journal of the Controlled Release Society, PubMed ID: 38795814
29, Zaeck LM, et al. Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA.1 and BA.5 boosters.Nature communications, PubMed ID: 38762522
30, Lee B, et al. SARS-CoV-2 infection exacerbates the cellular pathology of Parkinson's disease in human dopaminergic neurons and a mouse model.Cell reports. Medicine, PubMed ID: 38749422
31, He L, et al. Development of Broad-Spectrum Nanobodies for the Therapy and Diagnosis of SARS-CoV-2 and Its Multiple Variants.Molecular pharmaceutics, PubMed ID: 38920116
32, Yu F, et al. The histamine receptor H1 acts as an alternative receptor for SARS-CoV-2.mBio, PubMed ID: 38953634
33, Lu T, et al. Human angiotensin-converting enzyme 2-specific antisense oligonucleotides reduce infection with SARS-CoV-2 variants.The Journal of allergy and clinical immunology, PubMed ID: 38909634